Fulcrum Therapeutics, Inc. (FULC) vs Lexeo Therapeutics, Inc. (LXEO)

Fulcrum Therapeutics, Inc. and Lexeo Therapeutics, Inc. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and Lexeo Therapeutics, Inc. are of similar size ($288.8M and $278.3M). Across the 11 metrics below, Fulcrum Therapeutics, Inc. leads on 9 and Lexeo Therapeutics, Inc. on 2.

Valuation

Metric FULC LXEO Biotechnology median
P/E n/m n/m 7.88
P/S 3.46 n/m 11.47
P/B 0.92 1.21 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.35 n/m 0.74
EV/Sales (0.41) n/m 10.73
Earnings yield (32.35%) (34.74%) (28.84%)
Free cash flow yield (23.03%) (31.30%) (23.03%)

Profitability

Metric FULC LXEO Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (32.38%) (46.76%) (57.72%)
Return on assets (30.75%) (40.50%) (49.22%)
Return on invested capital 0.00% (253.48%) 0.00%

Growth

Metric FULC LXEO Biotechnology median
Revenue growth (TTM) 1,939.80% — 5.64%
EPS growth (last fiscal year) (637.50%) 39.81% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FULC LXEO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.35 13.89 4.73
Net debt to EBITDA 4.23 1.67 0.96

Dividend

Metric FULC LXEO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric FULC LXEO Biotechnology median
Market cap 288.79m 278.28m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack